Tofacitinib 5 mg Tablets – TOFATIL Tablets

TOFATIL Tablets – Advanced Treatment for Prolonged Inflammatory Disorders.

Tofacitinib 5 mg Tablets, is an oral Janus Kinase (JAK) inhibitor that modulates the immune response by selectively targeting JAK enzymes. By blocking intracellular signaling pathways critical for immune activation.
Tofacitinib helps to control:
Joint inflammation and damage in arthritis.
Intestinal inflammation in ulcerative colitis.
Skin and joint manifestations in psoriatic arthritis.

Recommended by specialists:
✅Rheumatologists : To manage autoimmune disorders such as rheumatoid arthritis, and psoriatic arthritis.
✅Gastroenterologist : To manage moderate to severe ulcerative colitis.

Key benefits of  Tofacitinib 5 mg Tablets – TOFATIL Tablets
✅ Targeted Action : Specifically inhibits Janus Kinase (JAK) pathways, reducing inflammation at the cellular level while minimizing systemic effects.
✅Versatile Usage : Approved for multiple chronic inflammatory conditions, including rheumatoid arthritis, ulcerative colitis, and psoriatic arthritis.
✅ Rapid Onset : Provides faster symptom relief compared to conventional medication for inflammatory diseases.
✅ Oral administration : Easy to use oral tablet form, convenient alternative to injectable, improves patient’s compliance.

Indications-
✅ Rheumatoid Arthritis (RA) (moderate to severe)
✅ Psoriatic Arthritis (PsA)
✅ Ulcerative Colitis (UC) (moderate to severe)
✅ Ankylosing Spondylitis (AS) (investigational in some cases)